Related Experiment Video
Updated: Oct 5, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Should a Statin be Given to All Hypertensive Patients?
Daniel E McNavish1, Charles A German2, Michael D Shapiro3
1Department of Internal Medicine, Wake Forest University School of Medicine, Winston Salem, NC, USA.
Statin therapy can help prevent atherosclerotic cardiovascular disease (ASCVD) in patients with hypertension. Adding statins to blood pressure medication may further reduce cardiovascular event risk.
Area of Science:
- Cardiology
- Preventive Medicine
- Pharmacology
Background:
- Hypertension is a primary modifiable risk factor for atherosclerotic cardiovascular disease (ASCVD).
- Current guidelines recommend antihypertensive medication for stage 2 hypertension.
- Elevated ASCVD risk in hypertensive patients can be modified beyond blood pressure control.
Purpose of the Study:
- To review trials and literature on statin therapy for ASCVD prevention.
- To provide rationale for broader statin use in hypertensive patients.
Main Methods:
- Review of milestone trials and recent literature.
- Analysis of data from the HOPE-3 trial.
Main Results:
- The HOPE-3 trial showed statin therapy significantly reduced cardiovascular events in intermediate-risk individuals.
- Greatest benefit was observed in hypertensive patients within the HOPE-3 trial.
- Statin therapy may offer additional ASCVD risk reduction in patients treated for hypertension.
Conclusions:
- Patients with stage 2 hypertension and an indication for antihypertensive therapy may benefit from concurrent statin use for primary ASCVD prevention.
- Adding statin therapy to antihypertensive treatment can further mitigate cardiovascular event risk.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Angina IV: Management

